Erste Asset Management Gmb H Catalyst Pharmaceuticals, Inc. Transaction History

Erste Asset Management Gmb H

  • $8.35 Trillion
  • Q3 2024

Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 26, 2024
SELL
$11.69 - $15.02 $0 - $0
0 Closed
0 $0
Q2 2023

Nov 26, 2024
SELL
$11.5 - $18.08 $0 - $0
0 Closed
0 $0
Q1 2023

Nov 26, 2024
BUY
$14.34 - $21.05 $0 - $0
0 New
0 $0
Q4 2022

Nov 26, 2024
BUY
$12.25 - $19.5 $0 - $0
0 New
0 $0
Q3 2022

Nov 26, 2024
BUY
$7.06 - $15.52 $0 - $0
0 New
0 $0
Q2 2022

Nov 26, 2024
BUY
$6.23 - $8.57 $0 - $0
0 New
0 $0
Q1 2022

Nov 22, 2024
BUY
$5.31 - $8.31 $0 - $0
0 New
0 $0

Others Institutions Holding CPRX

# of Institutions
327
Shares Held
94.1M
Call Options Held
19.1K
Put Options Held
51.1K
View Full List

About CATALYST PHARMACEUTICALS, INC.

CPRX Quotes by TradingView
  • Ticker CPRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 102,820,000
  • Market Cap $2.33B
  • Description
  • Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies for people with rare debilitating, chronic neuromuscular, and neurological diseases in the United States. It offers Firdapse, an amifampridine phosphate tablets for the treatment of patients with lambert-eaton myasthe...
More about CPRX
Track This Portfolio

Track Erste Asset Management Gmb H Portfolio

Follow Erste Asset Management Gmb H and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Erste Asset Management Gmb H, based on Form 13F filings with the SEC.

News

Stay updated on Erste Asset Management Gmb H with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email